Send feedback

COL2A1 p.Glu142Asp

c.426A>T · rs34392760 · VCV258239

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 12 submitters
AlphaMissense
likely benign
0.0769 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 5.51%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
connective tissue disorder

Computational evidence

Protein change
AlphaMissense0.0769likely benign
REVEL0.289benign-leaning
SaProtLLR -7.04tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2all four deltas below 0.2 · T>C here scores Δ0.81 · evaluated, not missing
Constraint at this position
ConservationphyloP 2.3GERP 1.8, phastCons 1
Regional constrainto/e 0.83unconstrained · MANE · 7,716 bp · p 0.0078 · regional, not allelic
Overall
CADD20.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 5.51% European (non-Finnish) · 65,068/1,179,992 alleles
Filtering AF 5.48% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.46%
Overall 4.7% 75,881/1,614,054 alleles · common
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 7.16% 14
European (non-Finnish)grpmax 5.51% 18
Middle Eastern 5.49% 18
Remaining individualsnot grpmax-eligible 4.5% 22
Admixed American 3.13% 32
Amishnot grpmax-eligible 2.96% 34
Finnishnot grpmax-eligible 2.8% 36
South Asian 1.31% 76
African / African-American 0.874% 114
East Asian 0.0111% 8,978

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
COL2A1
Protein
p.Glu142Asp
Coding
c.426A>T
MANE Select
NM_001844
dbSNP
rs34392760
Type
single nucleotide variant
Location
chr12:47997874 (GRCh38)
Gene constraint
LOEUF 0.183 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 53.56 · 11 PDB
Residue 142
the 'disordered' region; a UniProt-annotated variant site (in)
Full COL2A1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/col2a1-p-glu142asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown